David A. Siegel Aravive, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.25 - $1.92 $175,833 - $270,080	-140,667 Reduced 87.58%	19,948 $25,000
Q1 2023 May 15, 2023	BUY	$1.29 - $2.46 $85,656 - $163,344	66,400 Added 70.48%	160,615 $321,000
Q4 2022 Feb 14, 2023	BUY	$1.2 - $1.83 $61,320 - $93,513	51,100 Added 118.52%	94,215 $124,000
Q3 2022 Nov 14, 2022	SELL	$0.61 - $1.03 $21,553 - $36,392	-35,333 Reduced 45.04%	43,115 $35,000
Q2 2022 Aug 15, 2022	SELL	$0.93 - $1.9 $17,112 - $34,960	-18,400 Reduced 19.0%	78,448 $77,000
Q1 2022 May 16, 2022	SELL	$1.85 - $2.75 $102,120 - $151,800	-55,200 Reduced 36.3%	96,848 $187,000
Q4 2021 Feb 14, 2022	SELL	$2.19 - $4.07 $64,228 - $119,364	-29,328 Reduced 16.17%	152,048 $333,000
Q3 2021 Nov 15, 2021	SELL	$3.67 - $5.8 $425,353 - $672,220	-115,900 Reduced 38.99%	181,376 $675,000
Q2 2021 Aug 16, 2021	BUY	$4.65 - $6.42 $154,845 - $213,786	33,300 Added 12.61%	297,276 $1.78 Million
Q1 2021 May 17, 2021	BUY	$5.11 - $9.24 $239,659 - $433,356	46,900 Added 21.61%	263,976 $1.74 Million
Q4 2020 Feb 16, 2021	SELL	$4.36 - $6.51 $50,576 - $75,516	-11,600 Reduced 5.07%	217,076 $1.22 Million
Q3 2020 Nov 16, 2020	BUY	$4.7 - $12.06 $347,391 - $891,390	73,913 Added 47.76%	228,676 $1.08 Million
Q2 2020 Aug 14, 2020	SELL	$5.18 - $14.81 $28,811 - $82,373	-5,562 Reduced 3.47%	154,763 $1.8 Million
Q1 2020 May 15, 2020	BUY	$3.5 - $13.77 $288,617 - $1.14 Million	82,462 Added 105.91%	160,325 $923,000
Q4 2019 Feb 14, 2020	BUY	$6.21 - $14.02 $382,331 - $863,169	61,567 Added 377.8%	77,863 $1.06 Million
Q3 2019 Nov 14, 2019	SELL	$5.2 - $8.68 $4,160 - $6,944	-800 Reduced 4.68%	16,296 $122,000
Q2 2019 Aug 14, 2019	SELL	$5.65 - $7.5 $26,555 - $35,250	-4,700 Reduced 21.56%	17,096 $103,000
Q1 2019 May 15, 2019	SELL	$3.35 - $8.27 $9,380 - $23,156	-2,800 Reduced 11.38%	21,796 $153,000
Q4 2018 Feb 14, 2019	BUY	$3.23 - $8.7 $79,445 - $213,985	24,596 New	24,596 $87,000

Others Institutions Holding ARAV

# of Institutions

Shares Held

28.1K

Call Options Held

Put Options Held

View Full List

About Aravive, Inc.

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

More about ARAV

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account